Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 8 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Lakis, Sotirios  [Clear All Filters]
Journal Article
Tsakiri, K., Kotoula V., Lakis S., üller J., Fostira F., Bobos M., et al. (2017).  Crizotinib Failure in a TPM4-ALK –Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation. JCO Precision Oncology. 1 - 7.
Papadopoulou, K., Murray S., Manousou K., Tikas I., Dervenis C., Sgouros J., et al. (2018).  Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.. Am J Cancer Res. 8(1), 2-15.
Papamitsou, T., Toskas A., Papadopoulou K., Sioga A., Lakis S., Chatzistamatiou M., et al. (2014).  Immunohistochemical study of immunological markers: HLAG, CD16, CD25, CD56 and CD68 in placenta tissues in recurrent pregnancy loss.. Histol Histopathol. 29(8), 1047-55.
Lakis, S., Dimoudis S., Kotoula V., Alexopoulou Z., Kostopoulos I., Koletsa T., et al. (2016).  Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.. Anticancer Res. 36(5), 2365-78.
Papamitsou, T., Chatzistamatiou M., Grammatikopoulou D., Papadopoulou K., Lakis S., Economou Z., et al. (2011).  Low expression of progesterone receptor A in intermediate trophoblast of miscarriages.. Histol Histopathol. 26(5), 609-14.
Polychronidou, G., Kotoula V., Manousou K., Kostopoulos I., Karayannopoulou G., Vrettou E., et al. (2018).  Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.. PLoS One. 13(12), e0208221.
Kotoula, V., Lakis S., Tikas I., Giannoulatou E., Lazaridis G., Papadopoulou K., et al. (2019).  Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients.. Gynecol Oncol. 152(2), 375-386.
Papaxoinis, G., Kotoula V., Giannoulatou E., Koliou G-A., Karavasilis V., Lakis S., et al. (2018).  Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.. Med Oncol. 35(7), 101.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.